These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. Mobarrez F, Egberg N, Antovic J, Bröijersen A, Jörneskog G, Wallén H. Thromb Res; 2012 Jan; 129(1):95-7. PubMed ID: 22035651 [No Abstract] [Full Text] [Related]
6. Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. Tehrani S, Mobarrez F, Antovic A, Santesson P, Lins PE, Adamson U, Henriksson P, Wallén NH, Jörneskog G. Thromb Res; 2010 Sep; 126(3):e225-31. PubMed ID: 20637495 [Abstract] [Full Text] [Related]
8. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions. Hamada M, Sugimoto M, Matsui H, Mizuno T, Shida Y, Doi M, Fukushima H, Nishio K, Yoshioka A, Shima M. Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018 [Abstract] [Full Text] [Related]
10. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects. Puccetti L, Bruni F, Bova G, Cercignani M, Palazzuoli A, Console E, Auteri A, Pasqui AL. Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702 [Abstract] [Full Text] [Related]
11. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. Bruni F, Pasqui AL, Pastorelli M, Bova G, Di Renzo M, Cercigani M, Leo A, Auteri A, Puccetti L. Int J Cardiol; 2004 Jun; 95(2-3):269-74. PubMed ID: 15193831 [Abstract] [Full Text] [Related]